Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015530
Filing Date
2024-11-13
Accepted
2024-11-13 16:15:45
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20240930x10q.htm   iXBRL 10-Q 1490320
2 EX-31.1 armp-20240930xex31d1.htm EX-31.1 15793
3 EX-31.2 armp-20240930xex31d2.htm EX-31.2 15392
4 EX-32.1 armp-20240930xex32d1.htm EX-32.1 8042
5 EX-32.2 armp-20240930xex32d2.htm EX-32.2 8474
6 GRAPHIC armp-20240930x10q001.jpg GRAPHIC 46817
  Complete submission text file 0001558370-24-015530.txt   6476303

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20240930.xsd EX-101.SCH 44504
8 EX-101.CAL armp-20240930_cal.xml EX-101.CAL 48906
9 EX-101.DEF armp-20240930_def.xml EX-101.DEF 163553
10 EX-101.LAB armp-20240930_lab.xml EX-101.LAB 404475
11 EX-101.PRE armp-20240930_pre.xml EX-101.PRE 304596
77 EXTRACTED XBRL INSTANCE DOCUMENT armp-20240930x10q_htm.xml XML 1025974
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 241454475
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)